Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
Molecular Weight:
621.75
Purity:
0.9992
CAS Number:
[2134096-06-1]
Formula:
C31H39N7O5S
Target:
EGFR
T9865
* VAT and and shipping costs not included. Errors and price changes excepted